They discovered that the expression of HERC3 was significantly downregulated in CRC tumor tissues and cell lines, and the downregulated HERC3 was closely related to shorter overall survival and disease-free survival in CRC patients [70]. The gene discussed is HERC3; the disease is neoplasm.